Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

US President Joe Biden has completed a round of radiation therapy as part of his prostate cancer treatment, according to ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

Adding PARP inhibitor niraparib to standard prostate cancer treatment delays disease progression in men with certain DNA ...

Sunak is an ambassador for Prostate Cancer Research, which is publishing a report on the costs and benefits of a targeted ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive ...